ABSTRACT. The dendritic cell (DC) network is a specialized system for presenting antigen to naive or quiescent T cells, and consequently plays a central role in the induction of T cell and B cell immunity in vivo. Despite considerable achievements in the last ten years, in our understanding of how DC induce and regulate immune responses, much remains to be learned about this complex system of cells. The history and current status of DC termed "directors of the immune system orchestra" is reviewed. The present understanding of DC cell biology, function and use, taking into account their complexity is discussed.
Members of the dendritic cell (DC) lineage have potent immunostimulatory properties and are widely distributed throughout the body. Although the principal function of DC appear to be activation of T cells [6, 37] , their diverse anatomic locations indicate that they have distinct strategies for differentiation and regulation of function [20, 48, 110, 122, 123, 173, 178] . This represents a control point for the onset of immunity. Distributed as sentinels throughout the body, DC are poised to capture antigen, migrate to draining lymphoid organs and after a process of maturation, select antigen specific lymphocytes to which they present the processed antigen, thus initiating clonal immunity. Circulating precursor DC enter peripheral tissues as immature DC where they capture microbial or viral antigens. Following antigen capture the immature DC leave the tissues and migrate to lymphoid organs, where after maturation, they display antigen-derived peptides on their MHC molecules, which in turn select out rare circulating antigen-specific T cells [Reviewed in 107] . These reactive T cells become activated and further induce terminal DC maturation, which support lymphocyte expansion and differentiation [141] . Activated T cells migrate back to the injured tissue, because they can selectively transverse inflamed epithelium. Helper T cells secrete lymphokines and cytotoxic T cells eventually lyse the infected cells [6] . As DC change in phenotype during their life span and thus do not carry stable surface markers, it is difficult to pinpoint individual phenotypes clearly within the huge family of DC, or even to use certain markers for ontogenic deductions. First identified in the epidermis in 1868, and then termed Langerhans cells (LC), DC presence in other tissues was identified 28 years ago, a century later [142] . These cells are present in low numbers in several tissues and studies have been hampered by low yield following purification [86, 87, 130, 171] . The question of whether DC originate from a separate lineage or belong to the monocyte/ macrophage family is still unresolved hitherto-in other words, the DC family tree has not yet been drawn.
DENDRITIC CELL ONTOGENY
Abundant evidence from studies, both in vivo and in vitro, indicates that DC in mouse spleen [149] , rat lymph [111] and mouse epidermis [42, 60] originate from bone marrow stem cells, although not all types of DC have been studied in this regard. Members of the dendritic leukocyte lineage are widely distributed throughout the body and their diverse anatomic distribution may perharps indicate different strategies for differentiation of each DC group. Most of the information regarding the process of DC differentiation has emerged from studies of cultured rat bone marrow cells [13, 62] . In a single study Bowers and Berkowitz showed that MHC class I negative bone marrow cells in the rat can develop into typical MHC class I positive DC. In similar experiments Steinman and Cohn [142] found that it was not possible to identify mature DC in the bone marrow by morphology. Great progress has been achieved in the last decade by several groups that have succeeded in the establishment of procedures for the in vitro generation of murine and human DC from progenitors in the bone marrow, placental and umbilical cord blood, and cytokine mobilized peripheral blood [16, 38, 51, 52, 79, 80, 91, 126, 151, 155, 156, 180] . Methods have also been developed to generate DC from blood monocytes [8, 112, 117, 119, 121] and murine peritoneal cavity macrophages [88] . Long-term DC lines have also recently been generated from fetal tissues using either granulocyte macrophage colony stimulating factor (GM-CSF) [173] or stromal cell culture supernatants [157] .
The observation that Langerhans cells (epidermal DC) and Peyer's patch DC expressing a macrophage marker (F4/ 80), are FcR and CR3 positive [116] suggests a lineage relationship with macrophages/monocytes. Studies of ontogenic development have revealed that tissue resident macrophages and dendritic cells are bone marrow derived cells and the intermediate stage of the macrophage is the circulating peripheral blood monocyte which is recruited into tissues to undergo differentiation into macrophages. The precursors of tissue DC may be peripheral blood DC, which have been well characterized in humans [68, [165] [166] [167] . A diagrammatic representation of the current understanding of the ontogeny of DC from stem cells is shown in Fig. 1 .
DENDRITIC CELL CLASSIFICATION
A wealth of information regarding DC biology has in the last decade been accumulated [6, 132] . The emerging picture from recent studies suggests that DC are a complex system of cells encompassing multiple subsets with potentially distinct biologic functions [124, 170] . The current accepted concept is that DC comprise three distinct subpopulations, including two within the myeloid lineage (LC and interstitial DC) and one within the lymphoid lineage [107] . DC can be classified on the basis of their tissue location as: interdigitating reticulum cells in the dome and inter follicular areas (IFA) of lymphoid organs [59, 168] ; Veiled cells (non lymphoid DC) in afferent lymph [61, 138] ; Blood DC when in circulation [136, 166] ; Langerhans cells in the epidermis [150] ; dermal DC when found in the dermis of the skin [142, 146] ; follicular DC, in B cell areas (follicles) of the spleen, lymph nodes and Peyer's patches [128] ; and interstitial DC, in the interstitial connective tissues of non-lymphoid organs [45] . Tissues from which DC have been isolated are summarized in Table 1 .
DENDRITIC CELL FEATURES
In our previous work on DC and other earlier studies [3, 21, 23, 69, 86, 87, 146] the principal features we used to differentially identify DC are: morphology; endocytic activity; enzyme activity; adherence properties; surface markers; and functional activity.
Morphology: Figures 2A and B illustrates the unusual shape that gives rise to the term "dendritic cell". As their name implies, DC are illegularly shaped cells that actively produce a variety of cell processes, including spiny dendrites, bulbous pseudopods, and lamellipodiae or veils. They have an oval orillegularly shaped nucleus that is pulsatile. The cytoplasma contains many oval phase-dense mitochondria, autophagolysosomes and a well-developed smooth endoplasmic reticulum. A ultra structural presentation of a DC is summarized in Fig. 3 [121, 122] ; and engulfment of apoptotic bodies [1, 120] . Several attempts have been made to reconcile the weak endocytic and strong antigen-presenting activities of DC [Reviewed in 144] .
Enzyme activity: DC in general, have few, if any, lysosomes, which explains their low lysosomal enzyme activity [64] . They therefore, stain very weakly, or not at all for acid phosphatase (AP) and beta-galactosidase [29, 86] , endogenous peroxidase [85, 111] ; non-specific esterase (NSE) [86, 87, 109, 133] or adenosine triphosphatase (ATPase) [7, 34, 86, 87, 111, 143] . Because of their potent antigen-presenting capacity, DC are expected to express an enzymatic armamentarium tailored to the degradation of virtually any antigen intopeptides. These antigens can be proteins, viruses, bacteria, mycobacteria, parasites and apoptotic bodies. Undoubtedly, their processing requires a very diverse set of enzymes. However little has been published to date on this topic. Proteolytic enzymes in DC are located in endosomal compartments, which also provide a low pH for antigen presenting cells (APC). By the action of hydrolytic enzymes, aspartic and cysteine proteinases, antigen is degraded into peptides which can be presented to T cells. Cathepsin D, an asparagyl protease, has been identified within human and murine DC [81, 122] . Other studies have also shown that cathepsin E is the major aspartic proteinase essential for the processing of antigen in DC [9] . DC have also been shown to express cathepsin S, an enzyme that has been shown to play a role in the processing of the invariant chain in B cell lines [115, 169] . A serine protease inhibitor (serpin) has been identified from subtractive cDNA libraries of CD40-activated DC [100] . Furthermore, a novel member of the disintegrin metalloproteinases, decysin, has been identified using cDNA subtraction libraries [101] . Further studies to identify DC specific enzymes need to be carried out.
Proliferative capacity: A feature of lymphoid DC is their failure to proliferate in culture [111] . The notion that DC are incapable of further cell division is based on several observations. Firstly, mitotic figures have never been observed in DC and DC do not divide when cultured [40] , even when stimulated by lipoplysaccharide (LPS) or concanavalin A in vitro [140] . Secondly, no labelled DC were detected in the gut lamina propria or peripheral lymph after intravenous injections of tritiated thymidine were administered [111] . Thirdly, in peripheral and lymphoid tissues DC are replaced by bone marrow precursors at a rate that can account for by the turnover time of the entire population [66] . However, evidence exists that Langerhans cells (LC) divide within the epidermis and that they exhibit mitotic figures [47, 96] . DC are radiation resistant in vitro and this may be related to their state as a non proliferating end cell. After irradiation and culture, they can be separated from radio-sensitive cells. Mixed lymphocyte stimulation by DC and the capacity of DC to act as accessory cells in vitro are not altered by X-irradiation [102] .
Membrane Markers: The DC complexity is enhanced by the fact that there is no single molecule known to be uniquely expressed by DC. The diverse anatomic distribution of members of the DC lineage indicates that they are a multi-potential end cell, depending on the site at which they meet antigen. The combination of several markers define a dendritic cell subpopulation and its stage of maturation. Molecules expressed by DC can be divided into: receptors for antigen up take; migration receptors; adhesion and costimulation molecules; cytokines; signalling molecules; antigen processing molecules; and other molecules [102, reviewed in 107] . Important molecules expressed by DC are summarized in Table 2 . Cell surface markers, which have been demonstrated on blood DC are summarized in Table 3 . Evidences, based on studies of LC suggest that cell surface markers CD80 (B7-1 orBB1) and CD86 (B7-2), the ligands for the T cell activation molecule CD28, are present on DC [79] . Two additional B7 family members, B7-H1/PD-L1 and B7h/B7RP-1, have been identified recently [32, 41, 154, 172] . In an effort to understand more about genes involved in DC function, a new member of the B7 family, B7-DC has been isolated [163] . In a series of experiments the authors were able to show that B7-DC strongly costimulates interferon (IFN) γ but not interleukin (IL)-4 or IL-10 production from isolated naïve T cells. These properties of B7-DC may account for some of the unique activity of DC, such as their ability to initiate potent T helper cell type 1 responses. Studies to elucidate the molecular basis for the differences in binding affinities of the B7 family members as well as their complete receptor complement need to be carried out.
Function: In terms of function, the unique and most critical function of DC is their ability to prime naïve T cells to proteins that require processing into peptides [21, 23] . They are the principal stimulators of primary immune responses [69, 101, 152, 165, 167] . Knight et al. [69] , investigated the role of veiled cells from lymph nodes or spleens of rats and mice in initiating immune responses in vivo. In their experiments, host versus graft responses were induced by injection of DC from spleens of F1 hybrid mice into foot-pads of parental strain and measured by the increase in the weight of the draining popliteal lymph node. The potency of DC to induce the responses was 100-fold greater than that of unseparated spleen cells.
DC are efficient stimulators of both allogeneic and syngeneic mixed lymphocyte reactions, MLR [53] . In studies of lymphoid DC as potent stimulators of the MLR in mice, Steinman and Witmer, [145] showed that a ratio of just one DC to 50-250 T cells induced maximal reaction. Prior to this finding it was thought that B cells and macrophages were the most potent stimulators of the MLR.
Dendritic cells act as accessory cells in the formation of anti-trintropheny l (TNP) cytotoxic cells (CTL), [90, 147] . In experiments involving murine DC the ability of DC to prime in vivo antigen specific cytotoxic T lymphocytes (CTL) after exposure to a soluble protein antigen in vitro was investigated by Mason et al. [90] . It was established that DC loaded in vitro with soluble protein antigens could prime cytotoxic T lymphocytes against tumor antigen in vivo. Most recently, tumor peptide pulsed DC-derived exo- somes have been successfully used to prime specific CTL in vivo and eradicate or suppress growth of established murine tumors [183] . Dendritic cells also act as accessory cells in oxidative mitogenesis [5, 109] , T cell proliferation to soluble antigens [116] , graft rejection [76] , and contact sensitivity [49, 70, 82] . DC are involved in autoimmune diseases [161, 184] , participate in the pathogenesis of HIV infection (84) and parasitic infections [97, 134] . Dendritic cells induce immune responses against parasite. The best-studied parasites of medical and veterinary importance are Leishimania major [12] and Toxoplasma gondii [134] . It remains to be determined whether the Toxoplasma parasites that invade the gut are directly taken up by DC or whether macrophages capture and process them [56] .
Isolation: The following properties have been shown to facilitate the isolation of DC: low buoyant density of DC compared to T cells and B cells [3, 69] ; selective adherence to tissue culture substrates [140] and lack of surface antigens when compared to T cells, B cells, monocytes, macrophages and natural killer cells [43, 68] .
In the mouse, where DC-specific antigens have been defined, positive selection approaches by magnetic cell sorting (MACS) [95] , panning [177] and cell sorting [26, 171] have been used for isolating and purifying spleen DC, utilizing antibodies directed against a variety of cell surface components: N418, anti CD11c [26]; 33D1, anti-lymphoid DC [103] ; anti MHC class I [137] ; anti-MHC class II [10]; anti CD8 [77] ; anti -ICAM-1; anti-CD54; anti-CD25; anti-CD28; anti-CD40 [71, 106, 159] ; anti-CD44; anti-CD54; anti-CD80, also known as B7-1 or BB1 [79] ; anti-CD83 [181, 182] ; anti-CD86, also termed B7-2; MOMA-1 and MOMA-2, anti-mouse DC; and NLDC-145 [94] ; anti-interdigitating cell [72] .
Negative selection using MACS separation [95] , panning [177] , erythrocyte rossetting [90] and cell sorting [26, 171] have been carried out using a range of lineage specific monoclonal antibodies: B5-5, anti-Thy-1.2 [101] ; anti-CD32 (FcrRII) [36] ; anti-CD45RA (B220) [94] ; SER-4 and F4/80, anti-macrophage [22] . Published data on DC isolation from lymphoid organs and blood indicate that the use of a single or successive 14.5% w/v metrizamide gradients gives the greatest recovery and purity [69, Personal communication, 84, 171] . In our previous work we have demonstrated the effectiveness of metrizamide gradients [86, 87, 89] . Recent studies have shown great progress in the establishment of several procedures for the in vitro generation of DC from progenitors in the bone marrow, placental and umbilical cord blood [16, 19, 38, 51, 52, 79, 80, 91, 126, 151, 155, 156, 180] ; monocytes [117, 119] and peritonealcavity macrophages [88] . This is likely to be the right way forward, since many experimental protocols devised to study the in vivo stimulatory potential and the molecular mechanisms involved in antigen processing of DC require large numbers of DC, approximately (10 8 -10 9 ).
CONCLUDING REMARKS
Although the tasks ahead to undertake DC studies are immense, considerable means and resources from academic, government, private and industrial sources are now being devoted to DC research than never before in Japan, the United States and Europe. Despite the apparent current considerable achievements in our understanding of how the DC system induces and regulates immune responses, much remains to be learned about this complex system of cells. Little is known about how DC induce peripheral tolerance and the interplay between DC and other components of the immune system. Studies need to be put underway to determine the DC status in various infectious diseases. Resolving these issues will definitely permit the therapeutic use of DC in human or animal patients to induce either immunity as is required during cancers and infectious diseases or tolerance as is required in allergy, autoimmunity and transplantation. The implications for the medical and veterinary importance of the therapeutic use of this complex yet useful and life saving cell system cannot be over emphasized.
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